Industry Praises PMA-Acceptance Draft Guidance, But Offers A Few Suggestions
This article was originally published in The Gray Sheet
Executive Summary
Companies are generally happy with FDA’s July 31 draft guidance describing a 15-day "acceptance review" that FDA staff will perform to quickly check that a PMA submission meets minimum requirements.
You may also be interested in...
FDA Finalizes 510(k), PMA, eCopy Guidances
FDA spells out its acceptance policies for 510(k) and PMA submissions, as well as guidelines for submitting electronic copies of submissions. The guidances all aim to make the device review process more efficient and speedy.
Washington Roundup, October 2012
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month we cover FDA’s enforcement action against CardioMEMS for alleged clinical trial violations, medical device user fee agreement implementation, and AdvaMed’s priority list for the fiscal-cliff bill.
Industry Says FDA’s “Refuse To Accept” 510(k) Guidance Is Too Subjective
Medical device firms generally support FDA’s “Refuse to Accept Policy for 510(k)s” draft guidance but have qualms with some of the new submission acceptance criteria the agency outlines.